Search Results
Jul 30, 2026, 06:45 ET RPC, Inc. Reports Second Quarter 2026 Financial Results And Declares Regular Quarterly Cash Dividend
business, including improved pricing and activity visibility, (ii) the opportunity to "support targeted growth through a modest increase in CapEx," (iii) the Company's ability to "invest opportunistically" based on its balance sheet, and (iv) the Company being "well positioned" with strong brands, a strong
More news about: RPC, Inc.
Jul 30, 2026, 06:30 ET Perpetua Resources, US Army, and Idaho National Laboratory Launch Critical Minerals Pilot Plant to Advance Antimony Trisulfide Supply
and the U.S. Army to advance the Project and America's antimony supply. Perpetua has received more than $59 million in Defense Production Act Title III funds from the U.S. Department of War. In June 2026, Perpetua was awarded up to an additional $4.7 million under the DOTC program, increasing the total
More news about: Perpetua Resources Corp.
Jul 30, 2026, 06:30 ET Columbus McKinnon Reports Record Orders and Sales in Q1 FY27; Increases FY27 Guidance
that the dividends payable on the Preferred Shares will be accrued, accumulated and compounded, rather than being paid in cash, during fiscal 2027; (iii) general economic trends and trends in our industry and markets; (iv) our ability to successfully integrate the Kito Crosby Acquisition and achieve targeted
More news about: Columbus McKinnon Corporation
Jul 30, 2026, 06:30 ET Xenia Hotels & Resorts Reports Second Quarter 2026 Results
such outbreaks, weather and climate-related events, such as hurricanes, tornadoes, floods, wildfires, and droughts, and natural or man-made disasters; (iii) inflation and inflationary pressures which increases labor costs and other costs of providing services to guests and complying with hotel brand standards,
More news about: Xenia Hotels & Resorts, Inc.
Jul 30, 2026, 06:00 ET Hyperscale Data Repurposes Bitcoin Treasury Strategy to Accelerate Development of Michigan AI Data Center
financing; andConverts digital assets into long-lived AI infrastructure expected to generate recurring cash flows.Milton "Todd" Ault III, Executive Chairman of Hyperscale Data, stated, "We believe our Bitcoin treasury is one of the Company's most valuable strategic assets.
More news about: Hyperscale Data Inc.
Jul 30, 2026, 06:00 ET The Cigna Group Reports Strong Second Quarter 2026 Results, Raises 2026 Outlook
services agreement issued by Cigna Healthcare; (ii) have access to Cigna Healthcare's provider network for covered services under their medical plan; or (iii) have medical claims that are administered by Cigna Healthcare.6. Margin, pre-tax, is calculated by dividing adjusted income (loss)
More news about: The Cigna Group
Jul 30, 2026, 05:09 ET NMPA Accepts New Indication Application for Sacituzumab Tirumotecan (sac-TMT) as First-Line Treatment for Advanced TNBC
The acceptance for review is based on the positive results from the randomized, open-label, multicenter Phase III registrational OptiTROP-Breast03 study evaluating the efficacy and safety of sac-TMT versus investigator's choice of chemotherapy in patients with unresectable
More news about: Kelun-Biotech
Jul 30, 2026, 03:53 ET EQPT Investors Have Opportunity to Lead EquipmentShare.com Inc Securities Lawsuit
(ii) EquipmentShare had not terminated or substantially reduced a number of the transactions with entities owned or controlled by the co-founders; (iii) as a result, EquipmentShare's financial statements were materially misleading; and (iv) as a result of the foregoing, defendants' positive statements
More news about: THE ROSEN LAW FIRM, P. A.
Jul 29, 2026, 21:50 ET POSCO announces the final tender results of its Offer to Purchase for cash up to US$400,000,000 aggregate principal amount of its outstanding 5.750% Notes due 2028
in its sole and absolute discretion, to (i) re-open or terminate the Offer, (ii) increase, decrease or eliminate the Maximum Acceptance Amount and (iii) otherwise amend or waive any of the terms and conditions of the Offer at any time, as described in the Offer to Purchase under the heading "Amendment
More news about: POSCO
Jul 29, 2026, 17:00 ET AGNICO EAGLE REPORTS SECOND QUARTER 2026 RESULTS - RECORD QUARTERLY FREE CASH FLOW REFLECTS SOLID OPERATIONAL PERFORMANCE; RECORD QUARTERLY SHAREHOLDER RETURNS
ounces starting as early as 2033. These projects include (i) a second shaft at Odyssey, (ii) the development of a satellite open pit at Marban, and (iii) the development of the Wasamac underground project. Marban and Wasamac are located approximately 12 kilometres and 100 kilometres from the Canadian
More news about: Agnico Eagle Mines Limited
Jul 29, 2026, 16:31 ET AMERICAN WATER REPORTS SOLID SECOND QUARTER 2026 RESULTS; AFFIRMS 2026 EPS GUIDANCE AND LONG-TERM TARGETS
company during 2026 related to the proposed merger with Essential Utilities, Inc. ("Essential Utilities"), (ii) impacts of weather during 2026, and (iii) incremental interest income through February 13, 2026 related to the 2024 amendment of the former Homeowner Services Group ("HOS") secured seller note.
More news about: American Water
Jul 29, 2026, 16:05 ET BAUSCH HEALTH ANNOUNCES SECOND QUARTER 2026 RESULTS, RAISES GUIDANCE
measure) adjusted for: (i) payments of legacy legal settlements, net of insurance recoveries and restitutions, (ii) payments of transformation costs, (iii) payments for separation costs and separation-related costs, (iv) interest payments charged against premium, (v) fees paid in connection with the debt
More news about: Bausch Health Companies Inc.
Jul 29, 2026, 16:05 ET CPKC reports strong Q2 results, poised for accelerated growth in second half of 2026
customers or foreign railroads and excludes the time and distance travelled by: i) trains used in or around CPKC's yards; ii) passenger trains; and iii) trains used for repairing track. An increase in average train speed indicates improved on-time performance resulting in improved asset utilization.
More news about: CPKC
Jul 29, 2026, 13:21 ET GRAL INVESTOR ALERT: GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit- Hagens Berman
that the study was optimally structured with a three-year follow-up period to demonstrate a statistically significant reduction in late-stage (Stage III and IV) cancer diagnoses.Concealment of Limitations: The action centers on whether GRAIL selectively promoted favorable top-line results
More news about: Hagens Berman Sobol Shapiro LLP
Jul 29, 2026, 11:30 ET INTU INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Intuit Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
tax-related business, particularly in its Turbo Tax business, as a result of, among other things, increasing competitive and pricing pressures; and (iii) accordingly, Intuit's previously issued 2026 TurboTax revenue growth guidance was unreliable and/or unrealistic.On May 20, 2026, during pre-market
More news about: Robbins Geller Rudman & Dowd LLP
Jul 29, 2026, 11:17 ET HAGENS BERMAN, SOBOL SHAPIRO LLP ALERT: GRAIL, Inc. (NASDAQ: GRAL) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed, August 4, 2026 Lead Plaintiff Deadline
that the study was optimally structured with a three-year follow-up period to demonstrate a statistically significant reduction in late-stage (Stage III and IV) cancer diagnoses.Concealment of Limitations: The action centers on whether GRAIL selectively promoted favorable top-line results
More news about: Hagens Berman Sobol Shapiro LLP
Jul 29, 2026, 10:31 ET Graves Ophthalmopathy Market Expected to Witness Rapid Expansion at a CAGR of 9% During the Forecast Period (2026-2036), Driven by the Recent Approval of Viridian's LUMVOA and the Launch of Emerging Therapies | DelveInsight
eye disease. The approval was granted under the FDA's Priority Review program and was supported by positive results from the pivotal Phase III THRIVE trial in active TED and the THRIVE-2 trial in chronic TED.The Graves' ophthalmopathy pipeline continues to expand, reflecting growing
More news about: DelveInsight Business Research, LLP
Jul 29, 2026, 10:30 ET Dermatology Devices Market worth $17.73 billion by 2031 - Exclusive Report by MarketsandMarkets™
Clinical Trial Services Market by Type (Laboratory, Monitoring, Recruitment, PV, Data Management), Phase (I, II, III), Therapy (Oncology, Neurology, Dermatology, CVD), Modality (Biologics, Devices), Delivery Model (FSP, Hybrid) - Global Forecast to 2030About
More news about: MarketsandMarkets
Jul 29, 2026, 10:09 ET REGN UPCOMING DEADLINE: Levi & Korsinsky Alerts Regeneron Pharmaceuticals, Inc. Stockholders of Securities Class Action - Contact the Firm
Time-Sensitive: Allegations focus on Regeneron's statements about clinical differentiation in the Phase III Fianlimab-Libtayo Study and the last-minute protocol amendment used to force a trial readout.NEW YORK, July
More news about: Levi & Korsinsky, LLP
Jul 29, 2026, 10:09 ET Levi & Korsinsky Reminds Grail, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 4, 2026 - GRAL
screening round that should have signaled the three-year trial design was insufficient to demonstrate a statistically significant reduction in Stage III and IV cancers. Rather than disclose these adverse trendlines, defendants allegedly framed the withholding of detailed first-round data
More news about: Levi & Korsinsky, LLP
Jul 29, 2026, 10:00 ET Caristo Diagnostics' CaRi-Heart® Coronary Inflammation Technology Authorized by U.S. FDA
the commercial launch of CaRi-Heart in the U.S. this quarter and expand during Q4 2026. The American Medical Association has assigned Category III Current Procedural Terminology (CPT®) codes 0992T and 0993T, which are applicable for CaRi-Heart, effective since January 1, 2026."With
More news about: Caristo Diagnostics
Jul 29, 2026, 09:15 ET Samaya AI Releases FrontierFinance, a New Public Benchmark for AI Agents in Investment Workflows; Samaya's AI System Outperforms Claude Fable 5 and GPT-5.6 Sol
while FrontierFinance covers a diverse range of use cases that are (i) central to the investment process, (ii) much more difficult to complete, and (iii) much harder to collect high quality evaluation data for. The use cases include Screening & Discovery, Company Research, Sector, Industry & Macro
More news about: Samaya AI
Jul 29, 2026, 09:00 ET Care For the Homeless Announces Transition of Leadership: President & CEO George Nashak to Retire; Executive Director Jonathan Santos-Ramos Named Successor
as Assistant Commissioner for Housing and Program Planning, a role in which he worked on the development and implementation of the New York/New York III Agreement and on other initiatives to promote permanency and to develop housing options for homeless people on the street and in shelters. His unique
More news about: Care for the Homeless
Jul 29, 2026, 08:30 ET Insilico Medicine Receives FDA Fast Track Designation for ISM6331, the AI-driven Pan-TEAD Inhibitor, in Advanced Mesothelioma
Phase III clinical trial for the treatment of idiopathic pulmonary fibrosis (IPF).With the Fast Track Designation, ISM6331 gains access to regulatory
More news about: Insilico Medicine
Jul 29, 2026, 08:00 ET REPUBLIC OF URUGUAY - ANNOUNCEMENT OF GLOBAL TENDER OFFER RESULTS
maximum purchase amount is (i) US$22,631,696 principal amount for the 2028 Ps. Bonds, (ii) US$49,675,066 principal amount for the 2027 USD Bonds and (iii) US$381,817,935 principal amount for the 2028 UI Bonds. Since the aggregate purchase price of all preferred tenders for the 2027 USD Bonds does not exceed
More news about: The Republic of Uruguay